Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.
Todd D. Hatajik
Advertisement
Todd D. Hatajik is a scientist at Pfizer Global Research and Development (Groton, CT).
Articles by Todd D. Hatajik
Advertisement
Latest Updated Articles
- Available Guidance and Best Practices for Conducting Forced Degradation Studies
Published: February 1st 2002 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
